Cutting R&D to Save Innovation

Aug 04, 2011

The pharmaceutical industry needs help — it is facing drastic cuts in personnel, pipelines drying up, patent cliffs looming, a lack of innovation. Many critics of the pharmaceutical industry say it doesn't help that companies are cutting back on R&D, either. But pharma veteran Bernard Munos says cutting R&D is actually what's going to save the industry, according to Forbes' Matthew Herper.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

A Start

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

Just Go 'Round the CDC

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

Student Visa Directive Rescinded

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

Cell Studies on Blood Features of Severe COVID-19 Cases, Infection-Related Phosphorylation Shifts, More

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.

Menu